NVCR
Price
$15.10
Change
-$0.49 (-3.14%)
Updated
Oct 22 closing price
Capitalization
1.76B
7 days until earnings call
Intraday BUY SELL Signals
TFX
Price
$136.78
Change
+$6.38 (+4.89%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
5.53B
14 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NVCR vs TFX

NVCR vs TFX Comparison Chart in %
View a ticker or compare two or three
VS
NVCR vs. TFX commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVCR is a StrongBuy and TFX is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for NVCR with price predictions
Oct 22, 2026

Momentum Indicator for NVCR turns positive, indicating new upward trend

NVCR saw its Momentum Indicator move above the 0 level on October 20, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned positive. In 67 of the 81 cases, the stock moved higher in the following days. The odds of a move higher are at 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NVCR's RSI Indicator exited the oversold zone, 24 of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 63%.

The Moving Average Convergence Divergence (MACD) for NVCR just turned positive on October 20, 2026. Looking at past instances where NVCR's MACD turned positive, the stock continued to rise in 38 of 48 cases over the following month. The odds of a continued upward trend are 79%.

Following a +11.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where NVCR advanced for three days, in 206 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

NVCR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVCR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

The Aroon Indicator for NVCR entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. NVCR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.201) is normal, around the industry mean (2.874). P/E Ratio (-11.615) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (40.950) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (2.634) is also within normal values, averaging (40.124).

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for TFX with price predictions
Oct 22, 2026

TFX in upward trend: price rose above 50-day moving average on October 22, 2026

TFX moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend. In 24 of 38 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 63%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on TFX as a result. In 48 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 58%.

The Moving Average Convergence Divergence (MACD) for TFX just turned positive on October 01, 2026. Looking at past instances where TFX's MACD turned positive, the stock continued to rise in 32 of 51 cases over the following month. The odds of a continued upward trend are 63%.

Following a +5.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where TFX advanced for three days, in 165 of 286 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TFX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.

TFX broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for TFX entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.902) is normal, around the industry mean (4.961). P/E Ratio (-5.657) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (0.165) is also within normal values, averaging (4.143). Dividend Yield (0.010) settles around the average of (0.005) among similar stocks. P/S Ratio (2.508) is also within normal values, averaging (56.876).

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. TFX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TFX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
NVCR vs TFX: Fundamental Ratings
NVCR
TFX
OUTLOOK RATING
1..100
413
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
16
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
5750
P/E GROWTH RATING
1..100
3497
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TFX's Valuation (16) in the Medical Specialties industry is significantly better than the same rating for NVCR (98). This means that TFX’s stock grew significantly faster than NVCR’s over the last 12 months.

TFX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NVCR (100). This means that TFX’s stock grew similarly to NVCR’s over the last 12 months.

TFX's SMR Rating (97) in the Medical Specialties industry is in the same range as NVCR (98). This means that TFX’s stock grew similarly to NVCR’s over the last 12 months.

TFX's Price Growth Rating (50) in the Medical Specialties industry is in the same range as NVCR (57). This means that TFX’s stock grew similarly to NVCR’s over the last 12 months.

NVCR's P/E Growth Rating (34) in the Medical Specialties industry is somewhat better than the same rating for TFX (97). This means that NVCR’s stock grew somewhat faster than TFX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVCRTFX
RSI
ODDS (%)
Bullish Trend 1 day ago
63%
Bearish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
68%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
58%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
63%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
53%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
52%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 7 days ago
58%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 9 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
71%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (NVCR: $15.59 vs. TFX: $130.40)
Brand notoriety: NVCR and TFX are both not notable
NVCR represents the Medical/Nursing Services, while TFX is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: NVCR: 234% vs. TFX: 55%
Market capitalization -- NVCR: $1.76B vs. TFX: $5.53B
NVCR [@Medical/Nursing Services] is valued at $1.76B. TFX’s [@Pharmaceuticals: Other] market capitalization is $5.53B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $156.8B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVCR’s FA Score shows that 0 FA rating(s) are green while TFX’s FA Score has 1 green FA rating(s).

  • NVCR’s FA Score: 0 green, 5 red.
  • TFX’s FA Score: 1 green, 4 red.
According to our system of comparison, both NVCR and TFX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVCR’s TA Score shows that 5 TA indicator(s) are bullish while TFX’s TA Score has 4 bullish TA indicator(s).

  • NVCR’s TA Score: 5 bullish, 3 bearish.
  • TFX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, NVCR is a better buy in the short-term than TFX.

Price Growth

NVCR (@Medical/Nursing Services) experienced а +12.64% price change this week, while TFX (@Pharmaceuticals: Other) price change was +5.77% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.74%. For the same industry, the average monthly price growth was -3.62%, and the average quarterly price growth was +9.09%.

Reported Earning Dates

NVCR is expected to report earnings on Oct 29, 2026.

TFX is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.62% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+0.74% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
NVCR
Daily Signal:
Gain/Loss:
TFX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

NVCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with ALGN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
-3.14%
ALGN - NVCR
38%
Loosely correlated
+2.74%
AZTA - NVCR
38%
Loosely correlated
-2.04%
TWST - NVCR
37%
Loosely correlated
-9.16%
A - NVCR
35%
Loosely correlated
-2.17%
TFX - NVCR
35%
Loosely correlated
+4.74%
More

TFX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TFX has been loosely correlated with A. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TFX jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TFX
1D Price
Change %
TFX100%
+4.74%
A - TFX
51%
Loosely correlated
-2.17%
RVTY - TFX
47%
Loosely correlated
+0.48%
TNDM - TFX
44%
Loosely correlated
+4.89%
SNN - TFX
42%
Loosely correlated
+5.64%
MTD - TFX
42%
Loosely correlated
+0.40%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PUI43.730.54
+1.25%
Invesco Dorsey Wright Utilities Momentum ETF (PUI)
PMDE26.34-0.03
-0.13%
PGIM S&P 500 Max Buffer ETF - December (PMDE)
GKAT45.63-0.09
-0.20%
Scharf Global Opportunity ETF (GKAT)
QLTY43.80-0.25
-0.57%
GMO US Quality ETF (QLTY)
IGLD19.60-0.46
-2.29%
FT Vest Gold Strategy Target Income ETF (IGLD)